AP NEWS

Global Oligonucleotide Synthesis Market Size, Share & Trends Analysis 2014-2025 by End Use, Product (Column-based, Array-based, Services) & Application (PCR Primer, FISH) - ResearchAndMarkets.com

November 19, 2018

DUBLIN--(BUSINESS WIRE)--Nov 19, 2018--The “Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report By End Use, By Product (Column-based, Array-based, Services), By Application (PCR Primer, FISH), And Segment Forecasts, 2018 - 2025” report has been added to ResearchAndMarkets.com’s offering.

The global oligonucleotide synthesis market size is expected to reach USD 3.9 billion by 2025 at a 12.4% CAGR during the forecast period. Continuous rise in usage of oligonucleotide synthesis across various aspects of human health management, from molecular diagnostics to therapeutics, is spurring revenue growth.

The recent success of oligonucleotide-based drugs in medicine due to increase in number of FDA-approved products is anticipated to boost revenue generation in this market. As of September 2017, there are six approved oligonucleotide therapeutic products.

A substantial number of oligos are being investigated for their usage in targeting various infectious diseases. For instance, dsDNA thioaptamers are reported to target the ribonuclease H (RNase H) domain of HIV-RT and are demonstrated to inhibit HIV-RT when used in vitro.

In addition, demand for cancer-related thioapatmers that can detect presence as well as target tumor growth factors, such as TGF-, is on a continuous rise. This, in turn, has led to increase in investments for exploring the significance of custom oligonucleotide synthesis in cancer research.

Key Topics Covered:

Chapter 1 Executive Summary

1.1 Market Snapshot

Chapter 2 Research Methodology

2.1 Information procurement

2.2 Information or Data Analysis

2.3 Market Formulation - Validation

2.4 Approaches for Market Estimation

Chapter 3 Oligonucleotide Synthesis Market Variables, Trends - Scope

3.1 Market Segmentation - Scope

3.1.1 Market driver analysis

3.1.1.1 Strong pipeline of oligonucleotide therapeutics in clinical trials

3.1.1.2 Changing regulatory environments for genetic research and its applications in healthcare

3.1.1.3 High R - D spending of pharmaceutical - biotechnology companies

3.1.1.4 Increased public - private spending on genomics

3.1.1.5 Technological advancements in gene editing technologies

3.1.1.6 Exponentially declining cost of sequencing

3.1.1.7 Rising demand for synthetic genes

3.1.2 Market restraint analysis

3.1.2.1 Need for advanced oligo synthesis solutions

3.1.2.2 High cost associated with genomics research

3.1.2.3 Increasing wages of skilled employees in life science sector

3.1.2.4 Lack of skilled professionals and research support in undeveloped countries

3.2 Penetration - Growth Prospect Mapping for Application, 2017

3.3 Oligonucleotide Synthesis -SWOT Analysis, By Factor (Political - Legal, Economic And Technological)

3.4 Industry Analysis - Porter’s

Chapter 4 Oligonucleotide Synthesis Market Categorization: Product Estimates - Trend Analysis

4.1 Global Oligonucleotide Synthesis Market: Product Movement Analysis, 2017 - 2025

4.2 Oligonucleotides

4.2.1 Global oligonucleotides market, 2014 - 2025 (USD Million)

4.2.2 Oligonucleotides, by product type

4.2.2.1 Column-based oligos

4.2.2.2 Array-based oligos

4.2.3 Oligonucleotides, by nucleic acid type

4.2.3.1 DNA oligos

4.2.3.2 RNA oligos

4.3 Equipment/ Synthesizers

4.4 Reagents

4.5 Services

4.5.1 Global oligonucleotide services market, 2014 - 2025 (USD Million)

4.5.2 Oligo synthesis

4.5.2.2 25 nmol

4.5.2.3 50 nmol

4.5.2.4 200 nmol

4.5.2.5 1,000 nmol

4.5.2.6 10,000 nmol

4.5.3 Purification

4.5.4 Modification

Chapter 5 Oligonucleotide Synthesis Market Categorization: Application Estimates - Trend Analysis

5.1 Global Oligonucleotide Synthesis Market: Application Movement Analysis, 2017 - 2025

5.2 PCR primers

5.3 PCR Assays - Panels

5.4 Sequencing

5.5 DNA Microarrays

5.6 Fluorescence In Situ Hybridization (FISH)

5.7 Antisense Oligonucleotides

5.8 Other Applications

Chapter 6 Oligonucleotide Synthesis Market Categorization: End Use Estimates - Trend Analysis

6.1 Global Oligonucleotide Synthesis Market: End Use Movement Analysis, 2017 - 2025

6.2 Pharmaceutical - Biotechnology Companies

6.3 Diagnostic Laboratories

6.4 Academic Research Institutes

Chapter 7 Oligonucleotide Synthesis Market Categorization: Regional Estimates - Trend Analysis, by Product, Applications, - End Use

7.1 Oligonucleotide Synthesis Market Share By Region, 2017 - 2025

Chapter 8 Competitive Landscape

Thermo Fisher Scientific, Inc. Merck KGaA GE Healthcare Dharmacon Inc. Agilent Technologies Bio-synthesis Kaneka Eurogentec S.A. Integrated DNA Technologies, Inc. BioAutomation LGC Biosearch Technologies Biolegio B.V.

For more information about this report visit https://www.researchandmarkets.com/research/g2shjn/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181119005363/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/19/2018 07:26 AM/DISC: 11/19/2018 07:26 AM

http://www.businesswire.com/news/home/20181119005363/en

AP RADIO
Update hourly